Viewing Study NCT04975256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-05-14 @ 5:33 PM
Study NCT ID: NCT04975256
Status: TERMINATED
Last Update Posted: 2024-12-16
First Post: 2021-07-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Sponsor: Mirati Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Metastatic Cancer View
None Malignant Neoplasm of Colon View
None Malignant Neoplasm of Lung View
None Malignant Neoplastic Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KRAS G12C View
None SOS1 Inhibitor View
None NSCLC View
None CRC View
None Non Small Cell Lung Cancer View
None Colon Cancer View
None Advanced Solid Tumor View
None Metastatic Cancer View
None Pancreatic Cancer View
None adagrasib View